J. M. Pioner

发表

RyR 2 mutation impairs atrial and ventricular contractility

S. Priori, C. Poggesi, E. Cerbai, 2015 .

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations

I. Olivotto, C. Poggesi, J. Tardiff, 2022, Frontiers in Physiology.

Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency

D. Mack, C. Poggesi, A. Gowran, 2022, Frontiers in Physiology.

Contractile properties of developing human fetal cardiac muscle

M. Bamshad, M. Regnier, A. Beck, 2016, The Journal of physiology.

Late sodium current inhibitors to treat exercise‐induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium

R. Matucci, A. Mugelli, I. Olivotto, 2018, British journal of pharmacology.

Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy

I. Olivotto, C. Poggesi, L. Sacconi, 2020, Frontiers in Physiology.

Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair.

Leonardo Sacconi, Corrado Poggesi, Raffaele Coppini, 2017, Small.

Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human induced pluripotent stem cells.

R. Moritz, M. Regnier, Deok‐Ho Kim, 2019, Cardiovascular research.

Full-length dystrophin deficiency leads to contractile and calcium transient defects in human engineered heart tissues

D. Mack, N. Sniadecki, Andrea Leonard, 2022, Journal of tissue engineering.

R4496C RyR2 mutation impairs atrial and ventricular contractility

S. Priori, C. Poggesi, E. Cerbai, 2016, The Journal of general physiology.

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy

M. Sherrid, A. Mugelli, I. Olivotto, 2019, JACC. Basic to translational science.

The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate.

C. Poggesi, A. Gowran, G. Pompilio, 2022, Journal of molecular and cellular cardiology.

Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

M. Regnier, Deok‐Ho Kim, D. Mack, 2016, Stem cell reports.

Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle

C. Poggesi, R. Coppini, C. Ferrantini, 2021, The Journal of general physiology.

A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study

C. Poggesi, R. Coppini, C. Ferrantini, 2019, Front. Cardiovasc. Med..

The relation between sarcomere energetics and the rate of isometric tension relaxation in healthy and diseased cardiac muscle

C. Poggesi, B. Colombini, C. Ferrantini, 2019, Journal of Muscle Research and Cell Motility.

Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models

A. Mugelli, I. Olivotto, C. Poggesi, 2017, Journal of the American Heart Association.

Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy

L. Loew, C. Poggesi, F. Pavone, 2016, Journal of molecular and cellular cardiology.

Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy

A. Mugelli, I. Olivotto, C. Poggesi, 2017, Circulation. Heart failure.

Optical Investigation of Action Potential and Calcium Handling Maturation of hiPSC-Cardiomyocytes on Biomimetic Substrates

M. Regnier, D. Mack, C. Poggesi, 2019, International journal of molecular sciences.

Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM

M. Regnier, F. Girolami, I. Olivotto, 2023, Circulation research.